Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

196 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Challenges to Using Big Data in Cancer.
Sweeney SM, Hamadeh HK, Abrams N, Adam SJ, Brenner S, Connors DE, Davis GJ, Fiore L, Gawel SH, Grossman RL, Hanlon SE, Hsu K, Kelloff GJ, Kirsch IR, Louv B, McGraw D, Meng F, Milgram D, Miller RS, Morgan E, Mukundan L, O'Brien T, Robbins P, Rubin EH, Rubinstein WS, Salmi L, Schaller T, Shi G, Sigman CC, Srivastava S. Sweeney SM, et al. Among authors: rubin eh. Cancer Res. 2023 Apr 14;83(8):1175-1182. doi: 10.1158/0008-5472.CAN-22-1274. Cancer Res. 2023. PMID: 36625843 Free PMC article. Review.
Case Studies for Overcoming Challenges in Using Big Data in Cancer.
Sweeney SM, Hamadeh HK, Abrams N, Adam SJ, Brenner S, Connors DE, Davis GJ, Fiore LD, Gawel SH, Grossman RL, Hanlon SE, Hsu K, Kelloff GJ, Kirsch IR, Louv B, McGraw D, Meng F, Milgram D, Miller RS, Morgan E, Mukundan L, O'Brien T, Robbins P, Rubin EH, Rubinstein WS, Salmi L, Schaller TH, Shi G, Sigman CC, Srivastava S. Sweeney SM, et al. Among authors: rubin eh. Cancer Res. 2023 Apr 14;83(8):1183-1190. doi: 10.1158/0008-5472.CAN-22-1277. Cancer Res. 2023. PMID: 36625851 Free PMC article. Review.
Preclinical and clinical pharmacodynamic assessment of L-778,123, a dual inhibitor of farnesyl:protein transferase and geranylgeranyl:protein transferase type-I.
Lobell RB, Liu D, Buser CA, Davide JP, DePuy E, Hamilton K, Koblan KS, Lee Y, Mosser S, Motzel SL, Abbruzzese JL, Fuchs CS, Rowinsky EK, Rubin EH, Sharma S, Deutsch PJ, Mazina KE, Morrison BW, Wildonger L, Yao SL, Kohl NE. Lobell RB, et al. Among authors: rubin eh. Mol Cancer Ther. 2002 Jul;1(9):747-58. Mol Cancer Ther. 2002. PMID: 12479371
Introducing new strategies in..
Abbruzzese JL, Eggermont AM, Rubin EH. Abbruzzese JL, et al. Among authors: rubin eh. Clin Cancer Res. 2010 Mar 1;16(5):1347. doi: 10.1158/1078-0432.CCR-10-0236. Epub 2010 Feb 23. Clin Cancer Res. 2010. PMID: 20179221 No abstract available.
Proceedings From the ASCO/College of American Pathologists Immune Checkpoint Inhibitor Predictive Biomarker Summit.
Hayes DF, Herbst RS, Myles JL, Topalian SL, Yohe SL, Aronson N, Bellizzi AM, Basu Roy U, Bradshaw G, Edwards RH, El-Gabry EA, Elvin J, Gajewski TF, McShane LM, Oberley M, Philip R, Rimm DL, Rosenbaum JN, Rubin EH, Schlager L, Sherwood SW, Stewart M, Taube JM, Thurin M, Vasalos P, Laser J. Hayes DF, et al. Among authors: rubin eh. JCO Precis Oncol. 2022 Nov;6:e2200454. doi: 10.1200/PO.22.00454. JCO Precis Oncol. 2022. PMID: 36446042 Free PMC article.
Assessment of added activity of an antitumor agent.
Chen C, Sun LZ, Ren Y, Rubin EH, Weinstock DM, Schmidt EV. Chen C, et al. Among authors: rubin eh. Contemp Clin Trials. 2022 Dec;123:106990. doi: 10.1016/j.cct.2022.106990. Epub 2022 Oct 30. Contemp Clin Trials. 2022. PMID: 36323343
196 results